advertisement

---

Buszewicz M 19

Showing records 1 to 19 | Display all abstracts from Buszewicz M

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Gazzard G
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Gazzard G; Konstantakopoulou E
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Konstantakopoulou E; Garway-Heath D
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Garway-Heath D; Garg A
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Garg A; Vickerstaff V
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Vickerstaff V
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Hunter R
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Hunter R; Ambler G
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Ambler G; Bunce C
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Bunce C; Wormald R
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Wormald R; Nathwani N
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Nathwani N
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Barton K
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Barton K
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Rubin G
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Rubin G
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Morris S
Health Technol Assess 2019; 23: 1-102

---

80617 Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Buszewicz M;
Lancet 2019; 393: 1505-1516

---

81394 Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT
Buszewicz M
Health Technol Assess 2019; 23: 1-102

---